{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:23:47Z","timestamp":1793654627204,"version":"4.5.1"},"reference-count":113,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":2003,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.fertnstert.2016.08.048","type":"journal-article","created":{"date-parts":[[2016,9,24]],"date-time":"2016-09-24T21:36:22Z","timestamp":1474752982000},"page":"1634-1647","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":324,"title":["Prevention and treatment of moderate and severe ovarian hyperstimulation syndrome: a guideline"],"prefix":"10.1016","volume":"106","author":[{"given":"Samantha","family":"Pfeifer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Butts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Dumesic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Fossum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarisa","family":"Gracia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"La Barbera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Mersereau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall","family":"Odem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Paulson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Penzias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margareta","family":"Pisarska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Rebar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Reindollar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Sandlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Vernon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Widra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2016.08.048_bib1","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.fertnstert.2013.12.026","article-title":"Oocyte number as a predictor for ovarian hyperstimulation syndrome and live birth: an analysis of 256,381 in\u00a0vitro fertilization cycles","volume":"101","author":"Steward","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib2","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.fertnstert.2009.05.092","article-title":"Factors associated with ovarian hyperstimulation syndrome (OHSS) and its effect on assisted reproductive technology (ART) treatment and outcome","volume":"94","author":"Luke","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib3","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.fertnstert.2012.05.042","article-title":"Prediction of in\u00a0vitro fertilization outcome at different antral follicle count thresholds in a prospective cohort of 1,012 women","volume":"98","author":"Jayaprakasan","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib4","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.3109\/00016340903287482","article-title":"Prediction of ovarian hyperstimulation syndrome in women undergoing in\u00a0vitro fertilization","volume":"88","author":"Kahnberg","year":"2009","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib5","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.fertnstert.2005.07.1292","article-title":"Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in\u00a0vitro fertilization cycles","volume":"85","author":"Papanikolaou","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib6","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0015-0282(16)57353-1","article-title":"Increased capillary permeability induced by human follicular fluid: a hypothesis for an ovarian origin of the hyperstimulation syndrome","volume":"63","author":"Goldsman","year":"1995","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib7","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/BF01204048","article-title":"Ovarian hyperstimulation syndrome: a review of pathophysiology","volume":"9","author":"Bergh","year":"1992","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib8","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0015-0282(00)00670-1","article-title":"Role of vascular endothelial growth factor in ovarian physiology and pathology","volume":"74","author":"Geva","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib9","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1172\/JCI4814","article-title":"Role of vascular endothelial cell growth factor in ovarian hyperstimulation syndrome","volume":"102","author":"Levin","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib10","first-page":"1967","article-title":"Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor\/vascular permeability factor in human granulosa cells: importance in ovarian hyperstimulation syndrome","volume":"80","author":"Neulen","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib11","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0140-6736(94)93001-5","article-title":"Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome","volume":"344","author":"McClure","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib12","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0015-0282(98)00484-1","article-title":"The pathogenesis of ovarian hyperstimulation syndrome: in\u00a0vivo studies investigating the role of interleukin-1b, interleukin-6, and vascular endothelial growth factor","volume":"71","author":"Pellicer","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib13","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0015-0282(00)00491-X","article-title":"The ovarian hyperstimulation syndrome","volume":"73","author":"Whelan","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib14","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0015-0282(16)58389-7","article-title":"Characterization of intraperitoneal cytokines and nitrites in women with severe ovarian hyperstimulation syndrome","volume":"66","author":"Revel","year":"1996","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib15","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/S0015-0282(97)81436-7","article-title":"Increased angiotensin II in ascites during severe ovarian hyperstimulation syndrome: role of early pregnancy and ovarian gonadotropin stimulation","volume":"67","author":"Delbaere","year":"1997","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib16","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1093\/HUMREP\/10.6.1355","article-title":"Inhibition of ovarian-derived prorenin to angiotensin cascade in the treatment of ovarian hyperstimulation syndrome","volume":"10","author":"Morris","year":"1995","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib17","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/s00404-015-3723-0","article-title":"Predictive factors of early moderate\/severe ovarian hyperstimulation syndrome in non-polycystic ovarian syndrome patients: a statistical model","volume":"292","author":"Ashrafi","year":"2015","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib18","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3109\/09513590.2013.875998","article-title":"Relationship between human chorionic gonadotropin serum levels and the risk of ovarian hyperstimulation syndrome","volume":"30","author":"Johnson","year":"2014","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib19","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12958-015-0067-3","article-title":"Ovarian hyperstimulation syndrome: a clinical report on 4894 consecutive ART treatment cycles","volume":"13","author":"Sousa","year":"2015","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib20","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0015-0282(00)00492-1","article-title":"Distinction between early and late ovarian hyperstimulation syndrome","volume":"73","author":"Mathur","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib21","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.2146\/ajhp070566","article-title":"Risk factors for ovarian hyperstimulation syndrome in Thai patients using gonadotropins for in\u00a0vitro fertilization","volume":"65","author":"Aramwit","year":"2008","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib22","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1093\/oxfordjournals.humrep.a019451","article-title":"Prediction of ovarian hyperstimulation syndrome by ultrasound volumetric assessment [corrected] of baseline ovarian volume prior to stimulation","volume":"11","author":"Danninger","year":"1996","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib23","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1093\/oxfordjournals.humrep.a138260","article-title":"The ovarian hyperstimulation syndrome in in-vitro fertilization: a Belgian multicentric study. I. Clinical and biological features","volume":"8","author":"Delvigne","year":"1993","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib24","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/humrep\/dem254","article-title":"Serum anti-Mullerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles","volume":"23","author":"Lee","year":"2008","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib25","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ejogrb.2009.11.017","article-title":"IVF outcome in women with PCOS, PCO and normal ovarian morphology","volume":"149","author":"Swanton","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib26","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.fertnstert.2005.10.052","article-title":"Elevated serum mullerian-inhibiting substance may be a marker for ovarian hyperstimulation syndrome in normal women undergoing in\u00a0vitro fertilization","volume":"85","author":"Nakhuda","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib27","doi-asserted-by":"crossref","first-page":"59.e1","DOI":"10.1016\/j.ajog.2014.02.026","article-title":"Characterization of women with elevated antimullerian hormone levels (AMH): correlation of AMH with polycystic ovarian syndrome phenotypes and assisted reproductive technology outcomes","volume":"211","author":"Tal","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib28","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s10815-011-9627-4","article-title":"Serum anti-Mullerian hormone and antral follicle count as predictive markers of OHSS in ART cycles","volume":"28","author":"Ocal","year":"2011","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib29","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1477-7827-7-86","article-title":"Comparison of follicular fluid and serum levels of Inhibin A and Inhibin B with calculated indices used as predictive markers of Ovarian Hyperstimulation Syndrome in IVF patients","volume":"7","author":"Moos","year":"2009","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib30","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1080\/14647270601021743","article-title":"Estimating the risks of ovarian hyperstimulation syndrome (OHSS): implications for egg donation for research","volume":"10","author":"Jayaprakasan","year":"2007","journal-title":"Hum Fertil (Camb)"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib31","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.fertnstert.2003.06.016","article-title":"Value of the serum estradiol level for preventing ovarian hyperstimulation syndrome: a retrospective case control study","volume":"81","author":"D'Angelo","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib32","first-page":"713","article-title":"Number of oocytes retrieved and resulting pregnancy. Risk factors for ovarian hyperstimulation syndrome","volume":"44","author":"Reljic","year":"1999","journal-title":"J Reprod Med"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib33","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1023\/B:JARG.0000027016.65749.ad","article-title":"Use of stimulated serum estradiol measurements for the prediction of hyperresponse to ovarian stimulation in in\u00a0vitro fertilization (IVF)","volume":"21","author":"Hendriks","year":"2004","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib34","doi-asserted-by":"crossref","DOI":"10.1093\/humrep\/dew051","article-title":"Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF\/ICSI cycles","author":"Toftager","year":"2016","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib35","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/PL00007479","article-title":"Significant reduction of the incidence of ovarian hyperstimulation syndrome (OHSS) by using the LHRH antagonist Cetrorelix (Cetrotide) in controlled ovarian stimulation for assisted reproduction","volume":"264","author":"Ludwig","year":"2000","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib36","doi-asserted-by":"crossref","first-page":"800","DOI":"10.3109\/09513590.2012.665103","article-title":"A randomized controlled trial of the GnRH antagonist ganirelix in Chinese normal responders: high efficacy and pregnancy rates","volume":"28","author":"Qiao","year":"2012","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib37","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1093\/humrep\/15.7.1490","volume":"15","author":"Borm","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib38","doi-asserted-by":"crossref","first-page":"8","DOI":"10.5935\/1518-0557.20160003","article-title":"Strategies for the management of OHSS: Results from freezing-all cycles","volume":"20","author":"Borges","year":"2016","journal-title":"JBRA Assist Reprod"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib39","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00404-009-1073-5","article-title":"Comparing GnRH agonist long protocol and GnRH antagonist protocol in outcome the first cycle of ART","volume":"281","author":"Firouzabadi","year":"2010","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib40","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1447-0756.2010.01247.x","article-title":"Comparison of gonadotropin-releasing hormone agonists and antagonists in assisted reproduction cycles of polycystic ovarian syndrome patients","volume":"36","author":"Hosseini","year":"2010","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib41","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/humrep\/dep436","article-title":"Flexible GnRH antagonist protocol versus GnRH agonist long protocol in patients with polycystic ovary syndrome treated for IVF: a prospective randomised controlled trial (RCT)","volume":"25","author":"Lainas","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib42","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00404-001-0267-2","article-title":"Use of GnRH antagonists in ovarian stimulation for assisted reproductive technologies compared to the long protocol. Meta-analysis","volume":"265","author":"Ludwig","year":"2001","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib43","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3109\/09513590.2010.526667","article-title":"Gonadotrophin-releasing hormone-antagonists vs long agonist in in-vitro fertilization patients with polycystic ovary syndrome: a meta-analysis","volume":"27","author":"Mancini","year":"2011","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib44","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3109\/09513590.2012.736561","article-title":"Effectiveness of GnRH antagonist in the treatment of patients with polycystic ovary syndrome undergoing IVF: a systematic review and meta analysis","volume":"29","author":"Xiao","year":"2013","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib45","doi-asserted-by":"crossref","first-page":"e106854","DOI":"10.1371\/journal.pone.0106854","article-title":"Comparisons of GnRH antagonist versus GnRH agonist protocol in supposed normal ovarian responders undergoing IVF: a systematic review and meta-analysis","volume":"9","author":"Xiao","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib46","first-page":"CD001750","article-title":"Gonadotrophin-releasing hormone antagonists for assisted reproductive technology","author":"Al-Inany","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib47","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0015-0282(02)03174-6","article-title":"Comparison of stimulation with clomiphene citrate in combination with recombinant follicle-stimulating hormone and recombinant luteinizing hormone to stimulation with a gonadotropin-releasing hormone agonist protocol: a prospective, randomized study","volume":"78","author":"Weigert","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib48","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s00404-009-1252-4","article-title":"Comparison of mild stimulation and conventional stimulation in ART outcome","volume":"281","author":"Karimzadeh","year":"2010","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib49","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s00404-012-2672-0","article-title":"Clomiphene combined with gonadotropins and GnRH antagonist versus conventional controlled ovarian hyperstimulation without clomiphene in women undergoing assisted reproductive techniques: systematic review and meta-analysis","volume":"287","author":"Figueiredo","year":"2013","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib50","first-page":"CD008528","article-title":"Clomiphene citrate in combination with gonadotropins for controlled ovarian stimulation in women undergoing in\u00a0vitro fertilization","volume":"11","author":"Gibreel","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib51","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1016\/j.fertnstert.2009.01.085","article-title":"Low-dose aspirin therapy to prevent ovarian hyperstimulation syndrome","volume":"93","author":"Varnagy","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib52","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.fertnstert.2007.08.037","article-title":"Low-dose acetylsalicylic acid plus prednisolone as an adjuvant treatment in IVF: a prospective, randomized study","volume":"90","author":"Revelli","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib53","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/humrep\/del025","article-title":"The use of metformin for women with PCOS undergoing IVF treatment","volume":"21","author":"Tang","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib54","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.fertnstert.2011.09.020","article-title":"Metformin reduces risk of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during gonadotropin-stimulated in\u00a0vitro fertilization cycles: a randomized, controlled trial","volume":"96","author":"Palomba","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib55","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1080\/01443610903147576","article-title":"Metformin in the treatment of clomiphene citrate-resistant women with polycystic ovary syndrome undergoing in\u00a0vitro fertilisation treatment: a randomised controlled trial","volume":"29","author":"Qublan","year":"2009","journal-title":"J Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib56","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/1471-0528.12070","article-title":"Effects of metformin in women with polycystic ovary syndrome treated with gonadotrophins for in\u00a0vitro fertilisation and intracytoplasmic sperm injection cycles: a systematic review and meta-analysis of randomised controlled trials","volume":"120","author":"Palomba","year":"2013","journal-title":"BJOG"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib57","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijgo.2015.04.046","article-title":"A systematic review and meta-analysis of metformin among patients with polycystic ovary syndrome undergoing\u00a0assisted reproductive technology procedures","volume":"131","author":"Huang","year":"2015","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib58","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1080\/00016340902835919","article-title":"Efficacy of metformin supplementation during ovarian stimulation of lean PCOS patients undergoing in\u00a0vitro fertilization","volume":"88","author":"Kumbak","year":"2009","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib59","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1093\/humrep\/der120","article-title":"Do women with ovaries of polycystic morphology without any other features of PCOS benefit from short-term metformin co-treatment during IVF? A double-blind, placebo-controlled, randomized trial","volume":"26","author":"Swanton","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib60","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/humrep\/16.1.24","article-title":"Prevention of severe ovarian hyperstimulation syndrome in IVF with or without ICSI and embryo transfer: a modified 'coasting' strategy based on ultrasound for identification of high-risk patients","volume":"16","author":"Al-Shawaf","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib61","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S0015-0282(98)00280-5","article-title":"Prevention of severe ovarian hyperstimulation by coasting","volume":"70","author":"Dhont","year":"1998","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib62","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.fertnstert.2009.02.049","article-title":"Ovarian hyperstimulation syndrome: steps to maximize success and minimize effect for assisted reproductive outcome","volume":"94","author":"Gera","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib63","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0015-0282(03)00548-X","article-title":"Comparison of coasting and intravenous albumin in the prevention of ovarian hyperstimulation syndrome","volume":"80","author":"Chen","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib64","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1093\/humrep\/14.6.1421","article-title":"Early unilateral follicular aspiration compared with coasting for the prevention of severe ovarian hyperstimulation syndrome: a prospective randomized study","volume":"14","author":"Egbase","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib65","first-page":"CD002811","article-title":"Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome","author":"D'Angelo","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib66","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1093\/humrep\/13.5.1157","article-title":"Does withholding gonadotrophin administration prevent severe ovarian hyperstimulation syndrome?","volume":"13","author":"Lee","year":"1998","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib67","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/14647270600787575","article-title":"The optimal length of 'coasting protocol' in women at risk of ovarian hyperstimulation syndrome undergoing in\u00a0vitro fertilization","volume":"9","author":"Nardo","year":"2006","journal-title":"Hum Fertil (Camb)"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib68","first-page":"99","article-title":"Does triggering ovulation by 5000 IU of uhCG affect ICSI outcome?","volume":"11","author":"Shaltout","year":"2006","journal-title":"Middle East Fertil Soc J"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib69","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ejogrb.2011.07.009","article-title":"Triggering final oocyte maturation with reduced doses of hCG in IVF\/ICSI: a prospective, randomized and controlled study","volume":"159","author":"Lin","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib70","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.fertnstert.2007.02.002","volume":"89","author":"Engmann","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib71","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1080\/09513590802404013","article-title":"Triggering with HCG or GnRH agonist in GnRH antagonist treated oocyte donation cycles: a randomised clinical trial","volume":"25","author":"Galindo","year":"2009","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib72","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.rbmo.2009.06.001","article-title":"GnRH agonist versus recombinant HCG in an oocyte donation programme: a randomized, prospective, controlled, assessor-blind study","volume":"19","author":"Melo","year":"2009","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib73","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s10815-009-9326-6","article-title":"Ovulation triggering with GnRH agonist vs hCG in the same egg donor population undergoing donor oocyte cycles with GnRH antagonist: a prospective randomized cross-over trial","volume":"26","author":"Sismanoglu","year":"2009","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib74","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S1472-6483(10)60200-3","article-title":"Complications related to ovarian stimulation and oocyte retrieval in 4052 oocyte donor cycles","volume":"17","author":"Bodri","year":"2008","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib75","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/humrep\/der463","article-title":"Reproductive outcome of fresh or frozen-thawed embryo transfer is similar in high-risk patients for ovarian hyperstimulation syndrome using GnRH agonist for final oocyte maturation and intensive luteal support","volume":"27","author":"Imbar","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib76","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.rbmo.2010.03.004","article-title":"GnRH agonist trigger for women with breast cancer undergoing fertility preservation by aromatase inhibitor\/FSH stimulation","volume":"20","author":"Oktay","year":"2010","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib77","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S1472-6483(10)60615-3","article-title":"Substituting HCG with GnRH agonist to trigger final follicular maturation\u2013a retrospective comparison of three different ovarian stimulation protocols","volume":"13","author":"Orvieto","year":"2006","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib78","first-page":"CD008046","article-title":"Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology","author":"Youssef","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib79","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1093\/humrep\/det249","article-title":"GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients","volume":"28","author":"Humaidan","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib80","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.rbmo.2009.11.018","article-title":"Cycles triggered with GnRH agonist: exploring low-dose HCG for luteal support","volume":"20","author":"Castillo","year":"2010","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib81","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.fertnstert.2015.06.011","article-title":"Risk factors for a suboptimal response to gonadotropin-releasing hormone agonist trigger during in\u00a0vitro fertilization cycles","volume":"104","author":"Meyer","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib82","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s10815-011-9708-4","article-title":"Comparison of cabergoline and intravenous albumin in the prevention of ovarian hyperstimulation syndrome: a randomized clinical trial","volume":"29","author":"Tehraninejad","year":"2012","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib83","first-page":"837","article-title":"Comparison of albumin and cabergoline in the prevention of ovarian hyperstimulation syndrome: A clinical trial study","volume":"11","author":"Torabizadeh","year":"2013","journal-title":"Iran J Reprod Med"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib84","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1210\/jc.2007-0409","article-title":"Dopamine agonist cabergoline reduces hemoconcentration and ascites in hyperstimulated women undergoing assisted reproduction","volume":"92","author":"Alvarez","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib85","first-page":"48","article-title":"Cabergoline for reducing ovarian hyperstimulation syndrome in assisted reproductive technology treatment cycles. A prospective randomized controlled trial","volume":"60","author":"Amir","year":"2015","journal-title":"J Reprod Med"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib86","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S1472-6483(10)60401-4","article-title":"Cabergoline reduces the early onset of ovarian hyperstimulation syndrome: a prospective randomized study","volume":"17","author":"Carizza","year":"2008","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib87","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ejogrb.2013.07.010","article-title":"Prevention of ovarian hyperstimulation syndrome in GnRH agonist IVF cycles in moderate risk patients: randomized study comparing hydroxyethyl starch versus cabergoline and hydroxyethyl starch","volume":"170","author":"Matorras","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib88","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.rbmo.2013.03.002","article-title":"Clinical outcome according to timing of cabergoline initiation for prevention of OHSS: a randomized controlled trial","volume":"26","author":"Seow","year":"2013","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib89","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ejogrb.2012.08.008","article-title":"Can dopamine agonist at a low dose reduce ovarian hyperstimulation syndrome in women at risk undergoing ICSI treatment cycles? A randomized controlled study","volume":"165","author":"Shaltout","year":"2012","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib90","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.fertnstert.2013.11.005","article-title":"Cabergoline for the prevention of ovarian hyperstimulation syndrome: systematic review and meta-analysis of randomized controlled trials","volume":"101","author":"Leitao","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib91","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0301-2115(95)02603-7","article-title":"Intravenous albumin prevents moderate-severe ovarian hyperstimulation in in-vitro fertilization patients: a prospective, randomized and controlled study","volume":"70","author":"Isik","year":"1996","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib92","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1093\/HUMREP\/10.6.1373","article-title":"Decreased incidence of severe ovarian hyperstimulation syndrome in high risk in-vitro fertilization patients receiving intravenous albumin: a prospective study","volume":"10","author":"Shalev","year":"1995","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib93","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0015-0282(16)56829-0","article-title":"Intravenous albumin for the prevention of severe ovarian hyperstimulation syndrome in an in\u00a0vitro fertilization program: a prospective, randomized, placebo-controlled study","volume":"62","author":"Shoham","year":"1994","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib94","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/humrep\/deg451","article-title":"Intravenous albumin does not prevent moderate-severe ovarian hyperstimulation syndrome in high-risk IVF patients: a randomized controlled study","volume":"18","author":"Bellver","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib95","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1093\/humrep\/16.9.1880","article-title":"The questionable use of albumin for the prevention of ovarian hyperstimulation syndrome in an IVF programme: a randomized placebo-controlled trial","volume":"16","author":"Ben-Chetrit","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib96","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.fertnstert.2006.11.170","article-title":"Human albumin does not prevent ovarian hyperstimulation syndrome in assisted reproductive technology program: a prospective randomized placebo-controlled double blind study","volume":"88","author":"Isikoglu","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib97","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000286379","article-title":"Administration of intravenous albumin around the time of oocyte retrieval reduces pregnancy rate without preventing ovarian hyperstimulation syndrome: a systematic review and meta-analysis","volume":"70","author":"Jee","year":"2010","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib98","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.fertnstert.2010.05.026","article-title":"Intravenous albumin administration for the prevention of severe ovarian hyperstimulation syndrome: a systematic review and metaanalysis","volume":"95","author":"Venetis","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib99","first-page":"CD001302","article-title":"Intra-venous fluids for the prevention of severe ovarian hyperstimulation syndrome","author":"Youssef","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib100","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.fertnstert.2014.09.046","article-title":"Calcium infusion for the prevention of ovarian hyperstimulation syndrome: a double-blind randomized controlled trial","volume":"103","author":"El-Khayat","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib101","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.fertnstert.2011.04.094","article-title":"Intravenous calcium infusion as a novel preventive therapy of ovarian hyperstimulation syndrome for patients with polycystic ovarian syndrome","volume":"96","author":"Gurgan","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib102","doi-asserted-by":"crossref","first-page":"248","DOI":"10.4103\/0974-1208.126293","article-title":"Calcium gluconate infusion is as effective as the vascular endothelial growth factor antagonist cabergoline for the prevention of ovarian hyperstimulation syndrome","volume":"6","author":"Naredi","year":"2013","journal-title":"J Hum Reprod Sci"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib103","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/S0015-0282(16)58275-2","article-title":"Comparison of intravenous albumin and transfer of fresh embryos with cryopreservation of all embryos for subsequent transfer in prevention of ovarian hyperstimulation syndrome","volume":"65","author":"Shaker","year":"1996","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib104","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1093\/humrep\/14.6.1457","article-title":"Elective cryopreservation of all pronucleate embryos in women at risk of ovarian hyperstimulation syndrome: efficiency and safety","volume":"14","author":"Ferraretti","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib105","first-page":"CD002806","article-title":"Embryo freezing for preventing ovarian hyperstimulation syndrome","author":"D'Angelo","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib106","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.fertnstert.2011.10.038","article-title":"Venous thromboembolism in relation to in\u00a0vitro fertilization: an approach to determining the incidence and increase in risk in successful cycles","volume":"97","author":"Rova","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib107","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0015-0282(16)60668-4","article-title":"Severe ovarian hyperstimulation syndrome: a reevaluated therapeutic approach","volume":"51","author":"Borenstein","year":"1989","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib108","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/aogs.12128","article-title":"Conservative medical treatment of ovarian hyperstimulation syndrome: a single center series and cost analysis study","volume":"92","author":"Casals","year":"2013","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib109","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1023\/A:1014828027282","article-title":"Aggressive outpatient treatment of ovarian hyperstimulation syndrome with ascites using transvaginal culdocentesis and intravenous albumin minimizes hospitalization","volume":"19","author":"Lincoln","year":"2002","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib110","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3109\/01443615.2012.663422","article-title":"Multiple transvaginal ascitic fluid aspirations improves the clinical and reproductive outcome in patients undergoing in\u00a0vitro fertilisation treatment complicated by severe early ovarian hyperstimulation syndrome","volume":"32","author":"Qublan","year":"2012","journal-title":"J Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib111","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1093\/oxfordjournals.humrep.a138601","article-title":"Day care management of severe ovarian hyperstimulation syndrome avoids hospitalization and morbidity","volume":"9","author":"Shrivastav","year":"1994","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib112","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S0015-0282(01)01784-8","article-title":"Hydroxyethylstarch versus human albumin for the treatment of severe ovarian hyperstimulation syndrome: a preliminary report","volume":"75","author":"Abramov","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.08.048_bib113","first-page":"711","article-title":"Conservative management of ovarian hyperstimulation syndrome","volume":"40","author":"Morris","year":"1995","journal-title":"J Reprod Med"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028216627814?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028216627814?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T12:33:50Z","timestamp":1768221230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028216627814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":113,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0015028216627814"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2016.08.048","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevention and treatment of moderate and severe ovarian hyperstimulation syndrome: a guideline","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2016.08.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a92016 American Society for Reproductive Medicine, Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}